Results 91 to 100 of about 77,938,455 (214)

Management of irritable bowel syndrome in primary care: feasibility randomised controlled trial of mebeverine, methylcellulose, placebo and a patient self-management cognitive behavioural therapy website (MIBS trial) [PDF]

open access: yes, 2010
Background: IBS affects 10-22% of the UK population. Abdominal pain, bloating and altered bowel habit affectquality of life, social functioning and time off work.
Tapp Laura   +24 more
core   +2 more sources

Alosetron: An Effective Treatment for Diarrhea-Predominant Irritable Bowel Syndrome

open access: yesWomen's Health, 2007
Serotonin (5-HT) is one of the key mediators of gut motility, secretion and sensation. Most 5-HT is localized in the gastrointestinal tract. Particularly important for gut function and regulation are the 5-HT1P, 5-HT3and 5-HT4receptors. These receptors have been the focus of research evaluating the pathophysiologic mechanisms of irritable bowel ...
Lucinda A, Harris, Lin, Chang
openaire   +2 more sources

Raised Amylase as a Potential Marker of Vascular Dysfunction and Inflammation in Fabry Disease

open access: yesJIMD Reports, Volume 67, Issue 6, November 2026.
ABSTRACT Fabry disease (FD) is a X‐linked disorder caused by deficiency of alpha‐galactosidase A (AGAL), leading to progressive accumulation of globotriaosylceramide (Gb3) and globotriaosylsphingosine (lyso‐Gb3). While renal, cardiac and cerebrovascular complications are well described, pancreatic involvement remains poorly characterised.
Simona D'Amore   +2 more
wiley   +1 more source

Sex Differences of Brain Serotonin Synthesis in Patients with Irritable Bowel Syndrome Using α-[11C]methyl-L-tryptophan, Positron Emission Tomography and Statistical Parametric Mapping

open access: yesCanadian Journal of Gastroenterology, 2003
BACKGROUND: Irritable bowel syndrome (IBS) is the most common functional bowel disorder and has a strong predominance in women. Recent data suggest that the brain may play an important role in the pathophysiology of IBS in the brain-gut axis.
Akio Nakai   +6 more
doaj   +1 more source

Sequelae of Traveler's Diarrhea: Focus on Postinfectious Irritable Bowel Syndrome [PDF]

open access: yesClinical Infectious Diseases, 2005
Traveler's diarrhea is usually an acute, self-limited illness; however, in some patients, enteric symptoms can persist for weeks, months, or years. It has been estimated that up to 3% of patients with traveler's diarrhea have symptoms for >30 days. The differential diagnosis includes persistent infection, coinfection, temporary postinfection phenomena,
openaire   +2 more sources

Complementary and alternative medicine use by patients in pediatric gastroenterology clinics

open access: yesJPGN Reports, Volume 7, Issue 4, Page 483-489, November 2026.
Abstract Objectives Use of complementary and alternative medicine (CAM) therapies among children seen in pediatric gastroenterology (GI) clinics is high. Multiple CAM therapies are effective as primary and adjuvant therapies for GI disorders and symptoms. Our study aimed to define the historical use of CAM and interest in CAM therapies in a specialized
Joshua D. Prozialeck   +3 more
wiley   +1 more source

Eluxadoline in the Treatment of Irritable Bowel Syndrome with Diarrhea

open access: yesClinical Medicine Reviews in Therapeutics, 2016
Irritable bowel syndrome (IBS) is a functional bowel disorder characterized by chronic abdominal pain and constipation (IBS-C), diarrhea (IBS-D), or a mixed pattern of altered bowel habits (IBS-M). It has a prevalence of 12% in North America with approximately one-third of patients having IBS-D in the United States.
openaire   +1 more source

ChREBP deficiency leads to diarrhea-predominant irritable bowel syndrome

open access: yesMetabolism, 2018
Fructose malabsorption is a common digestive disorder in which absorption of fructose in the small intestine is impaired. An abnormality of the main intestinal fructose transporter proteins has been proposed as a cause for fructose malabsorption. However the underlying molecular mechanism for this remains unclear. In this study, we investigated whether
Ah-Reum, Oh   +8 more
openaire   +4 more sources

Intestinal Permeability in Irritable Bowel Syndrome With and Without Comorbid Conditions: Results From the European DISCOvERIE Cohort

open access: yesUnited European Gastroenterology Journal, Volume 14, Issue 9, November 2026.
ABSTRACT Background Irritable bowel syndrome (IBS) is a disorder of gut‐brain interaction often accompanied by psychiatric and/or somatic comorbidities. Intestinal‐barrier dysfunction has been implicated in IBS pathophysiology. However, the contribution of psychiatric and somatic comorbidities to intestinal permeability remains unclear.
Alice Rustichelli   +33 more
wiley   +1 more source

Home - About - Disclaimer - Privacy